European Case Law Identifier: | ECLI:EP:BA:2002:T059299.20020801 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 01 August 2002 | ||||||||
Case number: | T 0592/99 | ||||||||
Application number: | 94303128.6 | ||||||||
IPC class: | A61K 31/135 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | B | ||||||||
Download and more information: |
|
||||||||
Title of application: | Controlled release formulation containing tramadol | ||||||||
Applicant name: | Euro-Celtique S.A. | ||||||||
Opponent name: | Krewel-Meuselbach GmbH Nycomed DAK A/S Bioglan Laboratories Ltd Lannacher Heilmittel Ges.m.b.H. Hexal Aktiengesellschaft Arzneimittelwerk Dresden GmbH |
||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Subject-matter of claim 1 of the patent in suit as granted extends beyond the application as filed - claimed subject-matter covers products not originally disclosed - technical contribution according to G 0001/93 | ||||||||
Catchwords: |
In the view of the Board, in the typical example given in point 16 of the decision G 0001/93, the expression "inventive selection" in the phrase "where the limiting feature is creating an inventive selection not disclosed in the application as filed or otherwise derivable therefrom" cannot mean anything other than a potential (inventive) selection - obviously, an opponent cannot be requested to demonstrate the potential character of the selection without making or preventing itself from making a further selection invention (Reasons No. 2.5) |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t990592eu1.html
Date retrieved: 17 May 2021
4 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: II Conditions to be met by an Application
XCLR II E 3.3 Addition to the claim of an undisclosed feature limiting protection conferred, without providing a technical contribution